Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of BMS-986278 in Pulmonary Fibrosis
jRCT2080225297Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD) comparing BMS-986278 with Placebo (2 arms). Started Jul 2020; status: completed.
02
Drugs
admilparant
03
Conditions
idiopathic pulmonary fibrosis (IPF)interstitial lung disease (ILD)
Beyond the preview
Go deeper on jRCT2080225297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225297.